• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Cosmetics
  • Various Updates on China’s Cosmetics Regulations

Various Updates on China’s Cosmetics Regulations

Thursday, 22 October 2020 / Published in Cosmetics, News, NMPA Registration in China

Various Updates on China’s Cosmetics Regulations

On September 21, the NMPA (National Medical Products Administration) released the administrative measures (draft) for cosmetics labeling in China. The draft covers new measures as highlighted below:

  • Permission to utilize electronic labels for cosmetics with small-sized packaging whilst the text “electronic label” must be clearly indicated
  • Permission to address the labeling information in the user manual or electronic label instead if the small-sized packaging of the cosmetic product does not provide enough space
  • If new terminologies are used on the packaging, their respective definitions should be indicated close by
  • Scientific evidence should be provided in detail for claims of efficacy, and the corresponding report should be prepared and published on the NMPA’s website accordingly

On September 28, the NMPA released three draft regulations including specific measures for imported cosmetics and ingredients:

Good manufacturing practices (GMP)

The draft GMP reflects the quality control requirements of “Practice for Cosmetics Production Licensing” issued in 2015 and aims to solve issues found in regulatory and supervisory practice.

According to the new CSAR (Cosmetics Supervision and Administration Regulation), cosmetic registrants, filers, and entrusted production companies should coordinate the cosmetics production in accordance with the requirements of the GMP for cosmetics and establish a cosmetics production quality management system to realize the control and traceability of the entire process of cosmetics material procurement, production, inspection, storage, sales, and recall. The GMP is divided into nine chapters, covering all aspects of cosmetic production and quality control:

• Chapter I General Rules
• Chapter II Institutions and Personnel
• Chapter III Quality Management
• Chapter IV Quality Control
• Chapter V Plant Facilities and Equipment
• Chapter VI Ingredients and Products
• Chapter VII Production Management
• Chapter VIII Product Sales Management
• Chapter IX Supplementary Rules
• Annex I Electronic Record Requirements for Cosmetics Production
• Annex II Environmental Requirements for Cosmetics Production Workshop

Specific measures for imported cosmetic ingredients:

  • Safety information and related document of proof should be obtained from the suppliers of imported ingredients and documented for future references
  • List of imported ingredients should be indicated with a corresponding Chinese name

Measures for adverse reactions

Cosmetic companies will carry more responsibilities for cosmetic adverse reactions monitoring and management, increasing industry self-regulation and enhanced product post-market surveillance:

  • NMPA must be notified immediately if any adverse events, product recalls, or safety alerts occurred outside of China
  • According to the investigation results of the adverse event, all provincial MPAs can coordinate with the NMPA to stop the importation of cosmetics if necessary  

Sampling inspection

Local MPAs will be in charge to arrange regular or occasional sampling inspections for cosmetics. Cosmetic manufacturers, operators, domestic registrants/filers, DRA (domestic responsible agents) and e-commerce platform operators will have to fully cooperate during sampling inspections.

  • The certificate of entry inspection and quarantine of imported cosmetics must be prepared before the sampling inspection
  • Chinese labeling is required
  • Non-conformities would require necessary actions to be taken, including product recalls, self-inspection, investigation on cause, and risk evaluation

On September 16, the NIFDC (National Institutes for Food and Drug Control) initiated the public consultation on the safety and technical standards for cosmetics (2015 edition) for future plans to draft an amended version.

By Jacky Li. Contact Cisema if you would like to learn more.

What you can read next

AI Medical Devices and SaMDs: Classification Guidelines Released
China's Medical Device Classification Sodium Hyaluronate
China’s Medical Device Classification of Sodium Hyaluronate Products is Now Open for Comments
changes during china drug registration
Changes during the China drug registration – Working procedures implemented

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.